1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 24100660 | Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation. | 2014 Feb | 1 |